Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Sep 27;1(3):125–132. doi: 10.12954/PI.13024

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2013 Asian Pacific Prostate Society (APPS)

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 3. — Kaplan-Meier estimates of overall survival according to docetaxel era (A) and the usage of docetaxel as first-line or second-line chemotherapy (B). (A) The patients after docetaxel era (after 2004) showed significantly longer overall survival (P=0.001; hazard ratio [HR], 0.65; 95% confidence interval [CI], 0.52 to 0.83). (B) The overall survival was longer in patients treated with docetaxel chemotherapy as second-line chemotherapy than in the patients treated with docetaxel chemotherapy as first-line chemotherapy. (P=0.002; HR, 0.60; 95% CI, 0.43 to 0.83).